Bristol-Myers Squibb ($BMY) generated 63 mentions from 7 distinct FinTwit voices over a 12-month period beginning July 17, 2025, with the most recent mention on June 26, 2026. Jacob Plieth (@jacobplieth) dominated discussion with 49 mentions, followed by Adam Feuerstein (@adamfeuerstein) with 16 mentions, while four other voices each contributed 1-2 mentions. Biotech-focused commentary formed the largest category of discussion around the stock.